COVID19 : Your Guide to prevention and control

The COVID-19 Vaccine

While strong measures are adopted and progress is made in containing the spread of the COVID-19 virus through better public health interventions, diagnostics and treatments, scientists across the world have accelerated the process to develop a safe and effective vaccine that will break the chain of transmission. Vaccines aim to expose the body to an antigen and provoke an immune response that can block or kill the virus if a person becomes subsequently infected, without causing the disease.

Two vaccines that have been granted emergency use authorization by the Central Drugs Standard Control Organization (CDSCO) in India are Covishield® (AstraZeneca’s vaccine manufactured by Serum Institute of India) and Covaxin® (manufactured by Bharat Biotech Limited).

Co-WIN is a platform for the citizens of India to Register for COVID-19 vaccination and schedule their vaccination slots at the nearest vaccination centers. To register yourself please log into https://www.cowin.gov.in/home.

You could also log into https://www.mohfw.gov.in/covid_vaccination/vaccination/index.html for Frequently Asked Questions and other information on COVID-19 vaccines

Revised Guidelines for Home Isolation of Mild/ Asymptotic COVID-19 cases

Ministry of Health and Family Welfare, Government of India recently issued revised guidelines on home isolation of mild/ asymptotic COVID-19 cases

As per the guidelines, the patients who are clinically assigned to be mild/asymptomatic are recommended for home isolation.

The asymptomatic cases are laboratory confirmed cases not experiencing any symptoms and having oxygen saturation at room air of more than 94%.

Clinically assigned mild cases are patients with upper respiratory tract symptoms (&/or fever) without shortness of breath and having oxygen saturation at room air of more than 94%.

Read More